Under construction – not a live service
Sign in

Information, not a decision

Endometrial cancer: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 13 Nov 2026

Open trials (438)

NCT07458347Phase 1A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationRecruiting
NCT07664735Phase 1A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.Recruiting
NCT05950464Phase 1Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial CancerRecruiting
NCT01174121Phase 2Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerRecruiting
NCT07197554Phase 1A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesRecruiting
NCT06270706Phase 1A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruiting
NCT04683653Phase 1/2Study of Pelvic Hypofractionated Radiotherapy in Endometrial CancerRecruiting
NCT05640999Phase 2Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPERRecruiting
NCT05112601Phase 2Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaRecruiting
NCT06515613Phase 1A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsRecruiting
NCT07503808Phase 1A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors TypesRecruiting
NCT06340568Phase 3A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruiting

426 more in the doctor's list on the site.

Phase 3 trials that ended in the last 90 days

NCT0259821926 Aug 2026Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.Completed

Guidelines

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 13 Nov 2026

https://frontlightresearch.com/en/doctor/endometrial-cancer/tumor-board